Literature DB >> 16318810

[The operative technique selection of lung transplantation for end-stage emphysema].

Ming-feng Zhen1, Jing-yu Chen, Feng Liu, Shu-min Dong, Yi-jun He, Qian-kun Zhu, Ruo Chen, Shu-gao Ye, Yong-gong Wang, Yang-hong Zhu.   

Abstract

OBJECTIVE: To investigate the operation of lung transplantation for end-stage emphysema.
METHODS: From September 2002 to February 2005, 9 patients with chronic obstructive pulmonary disease (COPD) underwent lung transplantation. The types of surgery included single lung transplantation in 2 patients, lung transplantation with asynchronous contralateral lung volume reduction (one week later) in 1, single lung transplantation with synchronized contralateral lung volume reduction in 4, and bilateral sequential lung transplantation without cardiopulmonary bypass in 2.
RESULTS: The volume of chest drainage was more than 2000 ml at the first postoperative day in 2 patients, one was reoperated for hemostasis and another was successfully responded to conservative therapy. The ventilation time was ranged from 3 to 22 days postoperatively. Two patients were received tracheotomy. Seven patients achieved good results, two of them had returned to work, and 1 patient had lived for 30 months. One patient was died of severe acute rejection (4A) at 15th postoperative day and 1 succumbed to multisystem organ failure due to severe bacterial infection combine fungal infection.
CONCLUSION: End-stage emphysema is an indication for single lung transplantation. Single lung transplantation with contralateral lung volume reduction is a good way to utilize donor. If patient suffered from infection, double-lung transplantation should be considered first.

Entities:  

Mesh:

Year:  2005        PMID: 16318810

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors.

Authors:  George Vaniotis; Irina Glazkova; Clémence Merlen; Carter Smith; Louis R Villeneuve; David Chatenet; Michel Therien; Alain Fournier; Artavazd Tadevosyan; Phan Trieu; Stanley Nattel; Terence E Hébert; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.